Dr Elizabeth Elliott (BSc MBBS MRCP)

Thesis title: Investigating the clinicopathological correlates amongst differing clinical phenotypes of MND


The John Walton Muscular Dystrophy Research Centre, Newcastle, Clinical Research Associate- 2016

The Anne Rowling Regenerative Neurology Clinic, Edinburgh, Clinical Research Fellow- 2018




Human Genetics with Basic Medical Sciences (BSc), King's College London-2009

Bachelor of Medicine and Bachelor of Surgery (MBBS), King's College London-2012

Member of the Royal College of Physicians (MRCP) UK-2016

Research summary

NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis.

(2021) J Pathol. Dec 9. Epub ahead of print. PMID: 34883532. DOI: 10.1002/path.5846.

Banerjee P, Elliott E, Rifai O, O'Shaughnessy J, McDade K, Abrahams S, Chandran S, Smith C, Gregory JM.


History and Examination Pivotal in Diagnosis of Bell’s Palsy. 

(2021) Practitioner, vol. 265, no. 1851, Practitioner Medical Publishing Ltd, pp. 17–20.

Elliott E and Davenport RJ.


Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective.

(2021) Brain Communications. https://doi.org/10.1093/braincomms/fcab242

Wong C, Stavrou M, Elliott E, Gregory JM et al.


Therapeutic targeting of proteostasis in amyotrophic lateral sclerosis - a systematic review and meta-analysis of preclinical research.

(2020) Frontiers in Neuroscience, Neurodegeneration. https://doi.org/10.3389/fnins.2020.00511

Elliott E, Bailey O, Waldron FM, Hardingham G, Chandran S, Gregory JM.


Neuronal clusterin expression is associated with cognitive protection in amyotrophic lateral sclerosis.

(2019) Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12575

Gregory J.M,  Elliott E,  McDade K,  Bak T,  Pal S,  Chandran S,  Abrahams S, Smith C. 


The molecular neuropathology of amyotrophic lateral sclerosis: protocol for systematic review and meta-analysis.

(2019) protocols.io. dx.doi.org/10.17504/protocols.io.bbnnimde

Elliott E, Gregory JM, Mehta AR, Chandran S, Smith C.


An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in Scotland.

(2019) Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. https://doi.org/10.1080/21678421.2019.1672748

Elliott E,  Newton J, Rewaj P, Gregory J.M, Tomarelli L, Colville S, Chandran S,  Pal S & On behalf of the CARE-MND Consortium.

Current project grants

MNDS & CSO Scottish Clinical Academic Training Fellowship

Conference details

Platform Presentations

ABN 2020 Annual Virtual Meeting. Unique inflammatory transcriptional profiles distiniguish between sALS cases of long and short disease duration.


Poster presentations

1. Unique inflammatory transcriptional profiles distinguish long from short disease duration ALS. RCP Glasgow Neurology conference, 6th March 2020.

2. A five year review of diagnostic neurodegenerative disease genetic testing, ABN 20-23 May 2019, Edinburgh, UK.

3. Therapeutic targeting of proteostasis in MND and FTD- a systematic review and meta-analysis of preclinical research,

      ENCALS 15-17 May 2019 Tours, France.

4. A baseline audit of Augmentative and Alternative Communication aid provision for people with MND in NHS Scotland,

      29th International Symposium on ALS/MND 7-9 December 2018 Glasgow, UK.

5. Audit of unplanned hospital admissions for patients with neuromuscular disorders in the North East,

      MRC 10th Annual Neuromuscular Translational Research Conference 22-23 March 2017 London, UK.